Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA – Get Rating) – Research analysts at Cantor Fitzgerald raised their FY2023 earnings per share (EPS) estimates for shares of Hepion Pharmaceuticals in a note issued to investors on Tuesday, April 11th. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will earn ($0.49) per share for the year, up […]
We have ranked penny stocks on the basis of their year-to-date return to develop this list of the 10 best performing penny stocks in the healthcare sector.
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA – Get Rating) shot up 8.8% during mid-day trading on Thursday . The stock traded as high as $0.75 and last traded at $0.74. 312,151 shares traded hands during mid-day trading, a decline of 58% from the average session volume of 736,713 shares. The stock had previously closed at $0.68. Wall […]
Hepion Pharmaceuticals (HEPA) Granted Additional Patent for rencofilstat streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.